Disruptive Technology Advisers LLC
CIK
1828550
Location
LOS ANGELES, CA
Portfolio Value
Micro
$22,908,022
Diversification
Highly concentrated
Filing Date
Global Rank
#6,110
/ 6,777
▼ 845
· as of Dec 2021
Top Industry
Drug Manufacturers - Specialty & Generic
72.7%
3Y Alpha vs SPY
+26.0%
Period ended 4 years ago
Filed Feb 2, 2022 · 4y
5 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+237.2%
SPY
+76.5%
Annualised alpha
+29.1%
Max drawdown
−76.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Dec 31, 2021 · Δ vs Sep 30, 2021Top Position
72.7%
+11.7 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
6,030
Highly concentrated+1,433
Portfolio Trend
5 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2021| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 72.7% | $16,652,706 |
| Technology | 27.3% | $6,255,316 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
2 positions ·
$22,908,022 total
· as of Dec 31, 2021
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
Reduced | 2,542,398 | $16,652,706 | 72.69% | |
| PATH |
UiPath, Inc.
Technology
|
Reduced | 145,034 | $6,255,316 | 27.31% |